Eptifibatide

CHEMBL1174 Phase 4 Aprobado Protein

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

832.0 g/mol

LogP

-2.4

Phase

4

This injectable medication prevents platelets from clumping together to form clots by blocking a key receptor on the platelet surface. It is used to treat acute coronary syndrome and during certain heart procedures.

Peso molecular

832,0000 g/mol

LogP

-2,40

TPSA

377,00 Å²

Regla de cinco de Lipinski

No cumple

Áreas terapéuticas

Systemic Lupus Erythematosus Stroke Cardiovascular Disease

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Estructura 2D

SVG PNG

Cite this structure

Embed this structure

SMILES

N=C(N)NCCCC[C@@H]1NC(=O)CCSSC[C@@H](C(N)=O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CC(=O)O)NC(=O)CNC1=O

InChI

InChI=1S/C35H49N11O9S2/c36-30(51)25-18-57-56-13-10-27(47)42-22(8-3-4-11-39-35(37)38)31(52)41-17-28(48)43-23(15-29(49)50)32(53)44-24(14-19-16-40-21-7-2-1-6-20(19)21)34(55)46-12-5-9-26(46)33(54)45-25/h1-2,6-7,16,22-26,40H,3-5,8-15,17-18H2,(H2,36,51)(H,41,52)(H,42,47)(H,43,48)(H,44,53)(H,45,54)(H,49,50)(H4,37,38,39)/t22-,23-,24-,25-,26-/m0/s1

Molecular Formula

C35H49N11O9S2

HBD / HBA

10 / 12

Enlaces Rotables

10

Átomos Pesados

57

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Preguntas frecuentes

This injectable medication prevents platelets from clumping together to form clots by blocking a key receptor on the platelet surface. It is used to treat acute coronary syndrome and during certain heart procedures.

Yes, Eptifibatide is an approved drug. It has reached clinical phase 4. It is classified as a Protein.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1174. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 448812. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

PillFYI

¿Busca información accesible para el paciente?

Eptifibatide en PillFYI

Estructura

Datos Rápidos

Fórmula: C35H49N11O9S2

Enlaces externos

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Aviso médico

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.